Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG

Autoimmunity

Volumn 35, Issue 3, 2002, Pages 183-190

  Oshima, Minako ^a   Deitiker, Philip ^a   Ashizawa, Tetsuo ^a   Atassi, M Zouhair ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Acetylcholine receptor; Immunosuppression; MHC; Myasthenia gravis; T cell

Indexed keywords

CHOLINERGIC RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2 PEPTIDE IA BETA B[62-76]; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 2; PEPTIDE FRAGMENT;

ALPHA CHAIN; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MODEL; EXPERIMENTAL MODEL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LYMPHOCYTE PROLIFERATION; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PROTECTION; T LYMPHOCYTE; TORPEDO CALIFORNICA; VACCINATION; ANIMAL; ANTIBODY PRODUCTION; C57BL MOUSE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; TORPEDO;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY FORMATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYASTHENIA GRAVIS, EXPERIMENTAL AUTOIMMUNE; PEPTIDE FRAGMENTS; RECEPTORS, CHOLINERGIC; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TORPEDO; VACCINATION; ANIMALS; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL;

EID: 0035993102     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930290022270     Document Type: Article

References (34)

1. Acetylcholine receptor antibodies in myasthenia gravis
2. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value
3. Myasthenia gravis: Stimulation of antireceptor autoantibodies by autoreactive T cell lines
4. Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients
5. Autoimmune T cell recognition of human acetylcholine receptor: The sites of T cell recognition in myasthenia gravis on the extracellular part of the α subunit
6. Immunotherapy in neuromuscular disorders: Current and future strategies
7. The role of thymus in myasthenia gravis
8. Experimental models of myasthenia gravis: Lessons in autoimmunity and progress toward better forms of treatment
9. In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor
10. Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: Inhibition with monoclonal anti-I-A antibodies
11. b on binding with and antigen presentation of Torpedo acetylcholine receptor α chain peptide 146-162
12. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: Positioning of T-cell receptors on HLA-DR2/peptide complexes
13. Suppression of experimental myasthenia gravis by monoclonal antibodies against MHC peptide region involved in presentation of a pathogenic T cell epitope
14. Profile of the continuous antigenic regions on the extracellular part of the α chain of an acetylcholine receptor
15. bm12 gene is evidence for genetic exchange between mouse immune response genes
16. Primary structure of α-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence
17. α-Neurotoxin binding to acetylcholine receptor: Localization of the full profile of the cobratoxin-binding regions on the α-chain of Torpedo californica acetylcholine receptor by a comprehensive synthetic strategy
18. High yield coupling of peptides to protein carriers
19. Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: Possible role of T cellbound Ia antigens as targets of immunoregulatory T cells
20. + B cell hybridomas to H-2-restricted T cell hybridomas
21. High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants
22. Use of immunoadsorbents for the study of antibody binding to sperm whale myoglobin and its synthetic antigenic sites
23. Experimental myasthenia gravis. A murine system
24. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide
25. T lymphocyte recognition of acetylcholine receptor: Localization of the full T cell recognition profile on the extracellular part of the α chain of Torpedo californica acetylcholine receptor
26. An immunodominant site of acetylcholine receptor in experimental myasthenia gravis mapped with T-lymphocyte clones and synthetic peptides
27. Profile of the regions of acetylcholine receptor α chain recognized by T-lymphocytes and by antibodies in EAMG-susceptible and non-susceptible mouse strains after different periods of immunization with the receptor
28. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides
29. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
30. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
31. A synthetic peptide from the third hypervariable region of major histocompatibility complex class II β chain as a vaccine for treatment of experimental autoimmune encephalomyelitis
32. B-cell activation in vitro by helper T cells specific to region α146-162 of Torpedo californica acetylcholine receptor
33. Localization and synthesis of the acetylcholine-binding site in the α-chain of the Torpedo californica acetylcholine receptor
34. Region of peptide 125-147 of acetylcholine receptor α subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies